ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, DCs and leukemic cells share common progeny, leading to the constitutive expression of putative tumor antigens, and up to 98% of myeloid DCs generated from peripheral blood mononuclear cells are BCR-ABL positive.